PDLIM2 Is a Marker of Adhesion and Β-Catenin Activity in Triple-Negative Breast Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-18-2787
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ERR Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Triple-Negative Breast Cancer

2018English

ΔNp63α Expression Induces Loss of Cell Adhesion in Triple-Negative Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Transgelin: A Potentially Useful Diagnostic Marker Differentially Expressed in Triple-Negative and Non–triple-Negative Breast Cancers

Human Pathology
Forensic MedicinePathology
2015English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Serum Expression of Β-Catenin Is a Potential Detection Marker in Patients With Colorectal Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

GABARAPL1 Acts as a Potential Marker and Promotes Tumor Proliferation and Metastasis in Triple Negative Breast Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy